Bell Bank’s Biogen BIIB Stock Holding History

Bell Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$250K	Sell	1,105 -4	-0.4%	-$848	0.01%	180
2026 Q2	$240K	Hold	1,109	–	–	0.01%	181
2026 Q1	$203K	Buy	+1,109	New	+$204K	0.01%	186
2024 Q4	–	Sell	-1,175	Closed	-$228K	–	191
2024 Q3	$228K	Hold	1,175	–	–	0.03%	164
2024 Q2	$272K	Hold	1,175	–	–	0.02%	168
2024 Q1	$253K	Hold	1,175	–	–	0.02%	173
2023 Q4	$304K	Hold	1,175	–	–	0.03%	155
2023 Q3	$302K	Hold	1,175	–	–	0.03%	154
2023 Q2	$335K	Buy	1,175 +1	+0.1%	+$298	0.04%	155
2023 Q1	$326K	Buy	1,174 +42	+4%	+$11.6K	0.03%	155
2022 Q4	$313K	Hold	1,132	–	–	0.04%	154
2022 Q3	$302K	Sell	1,132 -25	-2%	-$5.31K	0.04%	148
2022 Q2	$236K	Buy	1,157 +32	+3%	+$6.54K	0.03%	184
2022 Q1	$237K	Hold	1,125	–	–	0.03%	163
2021 Q4	$270K	Hold	1,125	–	–	0.03%	156
2021 Q3	$318K	Hold	1,125	–	–	0.04%	142
2021 Q2	$390K	Hold	1,125	–	–	0.05%	130
2021 Q1	$315K	Hold	1,125	–	–	0.05%	142
2020 Q4	$275K	Sell	1,125 -200	-15%	-$51.6K	0.04%	143
2020 Q3	$376K	Hold	1,325	–	–	0.07%	114
2020 Q2	$355K	Hold	1,325	–	–	0.07%	118
2020 Q1	$419K	Sell	1,325 -5	-0.4%	-$1.52K	0.09%	104
2019 Q4	$395K	Hold	1,330	–	–	0.07%	119
2019 Q3	$310K	Buy	1,330 +1	+0.1%	+$233	0.06%	135
2019 Q2	$311K	Buy	+1,329	New	+$307K	0.07%	127

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Bell Bank's BIIB Position: Q3 2026 in Review

Bell Bank reduced its Biogen (BIIB) stake by 0.36% in Q3 2026, selling an estimated $848 and leaving 1,105 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #180.

Bell Bank first reported a position in BIIB in Q2 2019 and has held it in 25 quarters since. The position peaked at $419K in Q1 2020. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Bell Bank held 1,105 shares of Biogen worth $250K as of Q3 2026.
Bell Bank sold 4 Biogen shares in Q3 2026, an estimated $848.
Biogen made up 0.01% of Bell Bank's portfolio in Q3 2026, its #180 holding.
Bell Bank first reported a position in Biogen in Q2 2019 and has held it in 25 quarters since.
Bell Bank's Biogen position peaked at $419K in Q1 2020.
881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Bell Bank's 13F filing for Q3 2026, filed 21 Oct 2026.